1-3 of 3
Jeffrey T. Billheimer
Close
Sort by
Journal Articles

Prospective testing for drug-dependent antibodies reduces the incidence of thrombocytopenia observed with the small molecule glycoprotein IIb/IIIa antagonist roxifiban: implications for the etiology of thrombocytopenia

Clinical Trials & Observations
Dietmar Seiffert, Andrew M. Stern, William Ebling, Richard J. Rossi, Yu Chen Barrett, Richard Wynn, Gregory F. Hollis, Bokang He, Cathy J. Kieras, Donna L. Pedicord, Debra A. Cromley, Tsushung A. Hua, Robert B. Stein, Robert N. Daly, Anthony Sferruzza, Henry J. Pieniaszek, Jeffrey T. Billheimer
Journal: Blood
Blood (2003) 101 (1): 58–63.
https://doi.org/10.1182/blood-2002-02-0471
Published: 2003
Journal Articles

Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated

Clinical Trials & Observations
Jeffrey T. Billheimer, Ira B. Dicker, Richard Wynn, Jodi D. Bradley, Debra A. Cromley, Helen E. Godonis, Lisa C. Grimminger, Bokang He, Cathy J. Kieras, Donna L. Pedicord, Susan M. Spitz, Beth E. Thomas, Nina I. Zolotarjova, Mary A. Gorko, Gregory F. Hollis, Robert N. Daly, Andrew M. Stern, Dietmar Seiffert
Journal: Blood
Blood (2002) 99 (10): 3540–3546.
https://doi.org/10.1182/blood.V99.10.3540
Published: 2002
Journal Articles

Impaired Ca 2+ -Induced Tyrosine Phosphorylation and Defective Lipid Scrambling in Erythrocytes From a Patient With Scott Syndrome: A Study Using an Inhibitor for Scramblase That Mimics the Defect in Scott Syndrome

David W.C. Dekkers, Paul Comfurius, Wim M.J. Vuist, Jeffrey T. Billheimer, Ira Dicker, Harvey J. Weiss, Robert F. A. Zwaal, Edouard M. Bevers
Journal: Blood
Blood (1998) 91 (6): 2133–2138.
https://doi.org/10.1182/blood.V91.6.2133
Published: 1998